GeneTex
United States (US)

Daxx peptide

Cat No. GTX27879

Application Blocking
Species Human
APPLICATION

Application Note

The peptide is used for blocking the activity of anti-Daxx (GTX22017). Incubatingthe peptide with equal volume of antibody for 30 min at 37ºC usually completely blocks theantibody activity in Western blotting.
PROPERTIES

Form

Liquid

Buffer

PBS pH7.2 with 10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl, 0.1% bovine serum albumin, and 0.02% sodium azide

Storage

Store the peptide at -20˚C, stable for one year.

Concentration

0.20 mg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Death Domain Associated Protein,Bing2,Dap6,Eap1,Daxx

Background

Daxx is a death domain containing important intermediate in the Fasmediatedapoptosis. It binds to death domain of Fas to enhance theapoptotic pathway and activate JNK pathway. It is widely expressed inhuman and mouse issue.

Research Area

Package List Price ($)
$ 179